Literature DB >> 19131349

Corin, atrial natriuretic peptide and hypertension.

Yiqing Zhou1, Jingjing Jiang, Yujie Cui, Qingyu Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19131349      PMCID： PMC2721430          DOI： 10.1093/ndt/gfn727

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  29 in total

Review 1.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy.

Authors:  Peter A Nigrovic; Daniel H D Gray; Tatiana Jones; Jenny Hallgren; Frank C Kuo; Blair Chaletzky; Michael Gurish; Diane Mathis; Christophe Benoist; David M Lee
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

3.  Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes.

Authors:  Faye Wu; Wei Yan; Junliang Pan; John Morser; Qingyu Wu
Journal:  J Biol Chem       Date:  2002-03-07       Impact factor: 5.157

4.  Functional deletion mutation of the 5'-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese.

Authors:  T Nakayama; M Soma; Y Takahashi; D Rehemudula; K Kanmatsuse; K Furuya
Journal:  Circ Res       Date:  2000-04-28       Impact factor: 17.367

5.  Genetic analysis of the atrial natriuretic peptide gene in essential hypertension.

Authors:  N Kato; T Sugiyama; H Morita; T Nabika; H Kurihara; Y Yamori; Y Yazaki
Journal:  Clin Sci (Lond)       Date:  2000-03       Impact factor: 6.124

6.  Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme.

Authors:  W Yan; F Wu; J Morser; Q Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

7.  Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes.

Authors:  M E Steinhelper; K L Cochrane; L J Field
Journal:  Hypertension       Date:  1990-09       Impact factor: 10.190

8.  Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin.

Authors:  Sabine Knappe; Faye Wu; Mary Rose Masikat; John Morser; Qingyu Wu
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

9.  Identification of domain structures in the propeptide of corin essential for the processing of proatrial natriuretic peptide.

Authors:  Sabine Knappe; Faye Wu; Mary Rose Madlansacay; Qingyu Wu
Journal:  J Biol Chem       Date:  2004-06-10       Impact factor: 5.157

10.  Genomic structures of the human and murine corin genes and functional GATA elements in their promoters.

Authors:  Junliang Pan; Bernd Hinzmann; Wei Yan; Faye Wu; John Morser; Qingyu Wu
Journal:  J Biol Chem       Date:  2002-08-01       Impact factor: 5.157
View more
  5 in total

Review 1.  Corin in natriuretic peptide processing and hypertension.

Authors:  Yiqing Zhou; Qingyu Wu
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

Review 2.  Corin in clinical laboratory diagnostics.

Authors:  Ningzheng Dong; Shenghan Chen; Wei Wang; Yiqing Zhou; Qingyu Wu
Journal:  Clin Chim Acta       Date:  2011-11-07       Impact factor: 3.786

3.  Corin mutation R539C from hypertensive patients impairs zymogen activation and generates an inactive alternative ectodomain fragment.

Authors:  Ningzheng Dong; Chaodong Fang; Yizhi Jiang; Tiantian Zhou; Meng Liu; Jianping Zhou; Jianzhong Shen; Koichi Fukuda; Jun Qin; Qingyu Wu
Journal:  J Biol Chem       Date:  2013-01-31       Impact factor: 5.157

Review 4.  Role of corin and atrial natriuretic peptide in preeclampsia.

Authors:  Y Zhou; Q Wu
Journal:  Placenta       Date:  2012-12-02       Impact factor: 3.481

Review 5.  Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension.

Authors:  Utkarsh Ojha; Sanjay Ruddaraju; Navukkarasu Sabapathy; Varun Ravindran; Pitchaya Worapongsatitaya; Jeesanul Haq; Raihan Mohammed; Vinod Patel
Journal:  Am J Cardiovasc Drugs       Date:  2021-12-08       Impact factor: 3.283
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.